Blog

The JPD blog includes news items and articles of interest to the PD research and PD patient communities. Jon Palfreman has been the primary contributor to this section since 2013 (his blog posts can be found here), joined in 2018 by Benjamin Stecher (his blog posts can be found here). In the specific sections, articles from these authors can be found and these blog posts and stories relating to PD are unique content created for the journal website. Jon Palfreman also authors two sections called Neuroscientist's Corner and The Patient Perspective. Benjamin Stecher additionally authors a section called Tomorrow Edition Extracts. Contributions from guest bloggers are also included.

 

Jon Palfreman’s Blog

Toward Personalized Medicine for Those with Parkinson’s

Posted by Jon Palfreman, PhD on 1 May 2017

Neurologists often remark that Parkinson’s is a highly variable disease. Persons with Parkinson’s not only acquire the disease at different ages, they also manifest different clinical profiles, displaying symptoms that can progress at strikingly different rates. Read more.

Last comment on by David Wisner,

Comment Icon |
Bookmark Icon Bookmark Recommend Icon Recommend Follow Icon Follow
| Bookmark | Recommend | Follow

Guest Blog

Mime Over Mind - a therapeutic tool to help manage Parkinson’s

Posted by Pim van Holst, on 20 September 2023

I was living the dream. I’d retired as head of art from a busy downtown Toronto high school, my husband and I had moved to a smaller town, and our children were ‘launched’. We were traveling a lot, and I regularly visited my ‘happy place’ - painting. Except something was wrong with my dominant hand.

Comment Icon
Bookmark Icon Bookmark Recommend Icon Recommend Follow Icon Follow
| Bookmark | Recommend | Follow

Neuroscientist's Corner

Interview: Caroline Tanner

Posted by Jon Palfreman, PhD on 7 September 2013

Caroline (Carlie) Tanner had always planned to specialize in family medicine. But while a medical student in Chicago, she fell under the spell of neurologist Harold Klawans. Klawans – one of the first neurologist to use levodopa therapy with PD patients – convinced the young doctor that Parkinson’s was an exciting area of research and practice. Says Tanner, “The idea of being able to intervene with a transformative therapy like levodopa was very attractive, so after some soul-searching, I switched my concentration from family medicine to neurology.”

Comment Icon
Bookmark Icon Bookmark Recommend Icon Recommend Follow Icon Follow
| Bookmark | Recommend | Follow

The Patient Perspective

The Importance of the World Parkinson Congress for People with Parkinson’s

Posted by Pim van Holst, on 29 August 2023

Attending the World Parkinson Congress for the first time was an awe-inspiring and transformative experience, bringing together a global community of people with Parkinson's disease, sparking empowerment and advocacy among attendees.

Comment Icon
Bookmark Icon Bookmark Recommend Icon Recommend Follow Icon Follow
| Bookmark | Recommend | Follow